Emily Singer commissions and edits scientist-written content and develops new resources for the community. She joined The Transmitter in 2023 and has previously held a variety of editorial roles at the Simons Foundation, including editor for neuroscience collaborations, and senior biology writer and contributing editor at Quanta Magazine. Before joining the foundation, she was biomedical editor at Technology Review.
Emily Singer
Chief opinion editor
The Transmitter
From this contributor
How insights from network theory can boost interdisciplinary efforts
Parents turn their skills to furthering autism research
Gender differences take center stage at autism conference
Education
- Certificate in science communication, University of California, Santa Cruz
- B.A. in biology, University of California, Santa Cruz
Fellowships
- AAAS Mass Media Fellowship
Explore more from The Transmitter
‘Push-pull’ recipe for neural wiring used in multiple brain regions
A versatile pair of proteins steers neurons toward their targets and helps establish the brain’s sensory maps, new studies suggest.
‘Push-pull’ recipe for neural wiring used in multiple brain regions
A versatile pair of proteins steers neurons toward their targets and helps establish the brain’s sensory maps, new studies suggest.
Reward-learning algorithm hardwired into dopamine circuit
The finding bolsters the canonical model of reward prediction error, which has come under scrutiny in recent years.
Reward-learning algorithm hardwired into dopamine circuit
The finding bolsters the canonical model of reward prediction error, which has come under scrutiny in recent years.
Exclusive: Brain and spinal cord institute halts research, citing funding problems
The Burke Neurological Institute, which calls itself “the only research institute in the U.S. dedicated to finding treatments to repair the brain and spinal cord,” ceased research operations on 22 May.
Exclusive: Brain and spinal cord institute halts research, citing funding problems
The Burke Neurological Institute, which calls itself “the only research institute in the U.S. dedicated to finding treatments to repair the brain and spinal cord,” ceased research operations on 22 May.